SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-21-060626
Filing Date
2021-02-26
Accepted
2021-02-26 16:36:09
Documents
1
Group Members
VERSANT AFFILIATES FUND V, L.P.VERSANT OPHTHALMIC AFFILIATES FUND I, L.P.VERSANT VANTAGE I GP, L.P.VERSANT VANTAGE I GP-GP, LLCVERSANT VANTAGE I, L.P.VERSANT VENTURE CAPITAL V (CANADA) LPVERSANT VENTURE CAPITAL VI, L.P.VERSANT VENTURES V (CANADA), L.P.VER

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d116905dsc13da.htm SC 13D/A 240570
  Complete submission text file 0001193125-21-060626.txt   242675
Mailing Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104 650-233-7877
Versant Venture Capital V, L.P. (Filed by) CIK: 0001589097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1
Business Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1 (857) 412-7018
Repare Therapeutics Inc. (Subject) CIK: 0001808158 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91542 | Film No.: 21689772
SIC: 2834 Pharmaceutical Preparations